Making good on the promise of genomics in healthcare: the NSW Health perspective
Deb Willcox(Reserve Bank of Australia), Shelley Rushton(Cancer Institute of New South Wales), Nigel Lyons(Reserve Bank of Australia), Tamara Lee(Reserve Bank of Australia), Yemima Berman(The University of Sydney), Sarah Norris(The University of Sydney), John Cannings(House of Representatives), Bronwyn Burgess(Hunter Genetics), Peter Kennedy(Reserve Bank of Australia), Martin Joseph Canova(New South Wales Department of Health), Celia Halliburton(Reserve Bank of Australia), Eva Pilowsky(Reserve Bank of Australia), Andrew Perkins(Reserve Bank of Australia), Antônio Penna(Reserve Bank of Australia), Cliff Meldrum(New South Wales Department of Health), Ronald J. Trent(John Radcliffe Hospital), Olivia Hibbitt(Reserve Bank of Australia)
Cited by 3
Related Papers
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental Retardation
|The American Journal of Human Genetics|2008|223
Hereditary Nonpolyposis Colorectal Cancer in 95 Families: Differences and Similarities between Mutation-Positive and Mutation-Negative Kindreds
|The American Journal of Human Genetics|2001|202